-+ 0.00%
-+ 0.00%
-+ 0.00%

IQVIA Holdings (IQV) Could Be 2% Overvalued As Guidance Rises After Q2 Beat

Simply Wall St·07/30/2026 22:16:59
Listen to the news

IQVIA Holdings (IQV) stock moved after the company released second quarter 2026 results that topped analyst estimates, raised full year revenue and earnings guidance, and reported further progress on its long running share repurchase program.

See our latest analysis for IQVIA Holdings.

IQVIA Holdings shares have climbed strongly in recent months, with a 90 day share price return of 50.72% and a 1 year total shareholder return of 27.94%. However, the 5 year total shareholder return is slightly negative at 4.28%.

If IQVIA's recent guidance lift has you looking across healthcare and data heavy businesses, it could be a good moment to check out 41 healthcare AI stocks for other potential ideas.

IQVIA Holdings now sits on a sharp 90 day run that contrasts with a flat 5 year record. Is this surge mainly a reset in how the stock is valued, or a cleaner reflection of the underlying business progress that recent guidance points to?

Most Popular Narrative: 2.5% Overvalued

The most followed narrative currently places IQVIA Holdings' fair value at $232.00, slightly below the last close at $237.79. This frames the recent price strength in a tighter valuation range.

Accelerated adoption of AI-driven analytics and data solutions, supported by strong client demand and high-profile industry partnerships like NVIDIA, positions IQVIA for improved operational efficiency, faster project execution, and differentiation, which should support future revenue growth and eventual margin expansion as AI capabilities scale.

Read the complete narrative.

Curious what sits behind that AI driven story? The narrative leans on specific revenue, margin, and earnings paths that have to line up almost perfectly. The underlying assumptions are far more detailed than a simple growth rate.

Result: Fair Value of $232.00 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, IQVIA Holdings still faces CRO pricing pressure and high leverage, which could weigh on margins and make the AI driven growth story more difficult to deliver.

Find out about the key risks to this IQVIA Holdings narrative.

Another View on IQVIA Holdings Valuation

The most followed IQVIA Holdings narrative leans on a detailed earnings path and a fair value of $232.00. Yet on simple P/E math the picture looks different. IQV trades on 28.5x earnings, lower than peer averages of 44.8x and 37.1x, but slightly above its own fair ratio of 26.2x. That mix of relative discount and small premium raises a practical question for you: is the bigger risk that the stock drifts closer to peer levels or toward its own fair ratio?

See what the numbers say about this price — find out in our valuation breakdown.

NYSE:IQV P/E Ratio as at Jul 2026
NYSE:IQV P/E Ratio as at Jul 2026

Next Steps

Mixed signals around IQVIA Holdings can be useful if you take the time to pull apart the numbers yourself and decide what really matters. If you want a concise snapshot of the main concerns and bright spots that others are focused on, take a look at the 3 key rewards and 1 important warning sign.

Looking for more investment ideas beyond IQVIA Holdings?

IQVIA Holdings might be front of mind today, but the next opportunity on your list could come from a completely different corner of the market.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.